FACT

FACT II Acquisition Corp

There isn't enough reported data to score FACT yet.

IREN

IREN Limited

There isn't enough reported data to score IREN yet.

FACT Fundamentals

MetricStatus
Unavailable
Stable
N/A
N/A

FACT's profitability is currently stable. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like FACT.

IREN Fundamentals

MetricStatus
Under pressure
Weak
N/A
N/A

IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.

FACT PE Valuation

CHEAPFAIREXPENSIVE25x50x76x101x
CHEAPFAIREXPENSIVE25x50x76x101x
LevelPEPriceVs current
Cheap49x$8.73-19%
Fair53x$9.53-12%
Current60x$10.79—
Expensive96x$17.29+60%

Historical ranges are pointers, not guarantees.

FACT's PE is 60x, but its earnings don't support one, so it isn't a reliable read right now.

IREN PE Valuation

IREN has no meaningful PE right now: it lost money over the past year.

FACT Forward outlook

There aren't enough analyst estimates for FACT to show an outlook.

IREN Forward outlook

MetricOutlook
--
Losses growing
Strong growth
Strongly improving
Limited
Low

Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.

FACT Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $10.79 on Nov 12.

There is not enough scenario data to compare FACT and IREN's risk to reward.

IREN Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $19.48 on Nov 12.

There is not enough scenario data to compare FACT and IREN's risk to reward.

FACT Earnings Per Share

Q2 2024: $-8.73Q3 2024: $-3.55Q4 2024: $-1.04Q1 2025: $-0.60Q2 2025: $0.11Q3 2025: $0.20Q4 2025: $0.22Q1 2026: $0.22Q2 2026: $0.20Q3 2026: $0.18
Q2 2024: $-8.73Q3 2024: $-3.55Q4 2024: $-1.04Q1 2025: $-0.60Q2 2025: $0.11Q3 2025: $0.20Q4 2025: $0.22Q1 2026: $0.22Q2 2026: $0.20Q3 2026: $0.18
QuarterTTM EPSYoY
Q3 2026$0.18-10%
Q2 2026$0.20+82%
Q1 2026$0.22+$0.82
Q4 2025$0.22+$1.26
Q3 2025$0.20+$3.75
Q2 2025$0.11+$8.84
Q1 2023$0.11+57%
Q4 2022$0.13+8.3%

FACT has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.

IREN Earnings Per Share

Q4 2023: $-0.29Q1 2024: $-0.16Q2 2024: $-0.20Q3 2024: $-0.39Q4 2024: $-0.44Q1 2025: $-0.59Q2 2025: $0.25Q3 2025: $1.60Q4 2025: $1.18Q1 2026: $0.51Q2 2026: $-2.22Q3 2026: $-3.96
Q4 2023: $-0.29Q1 2024: $-0.16Q2 2024: $-0.20Q3 2024: $-0.39Q4 2024: $-0.44Q1 2025: $-0.59Q2 2025: $0.25Q3 2025: $1.60Q4 2025: $1.18Q1 2026: $0.51Q2 2026: $-2.22Q3 2026: $-3.96
QuarterTTM EPSYoY
Q3 2026-$3.96-347%
Q2 2026-$2.22-988%
Q1 2026$0.51+$1.10
Q4 2025$1.18+$1.62
Q3 2025$1.60+$1.99
Q2 2025$0.25+$0.45
Q1 2025-$0.59-$0.43
Q4 2024-$0.44-$0.15

IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.

FACT Quarterly Revenue

Q4 2023: $63MQ1 2024: $10MQ2 2024: $4MQ3 2024: --Q4 2024: $94MQ1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0Q3 2026: --
Q4 2023: $63MQ1 2024: $10MQ2 2024: $4MQ3 2024: --Q4 2024: $94MQ1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0Q3 2026: --
QuarterRevenueYoY
Q4 2024$94.2M+49%

FACT's revenue has slid since its 2024 peak: $0 last quarter.

IREN Quarterly Revenue

Q4 2023: $42MQ1 2024: $54MQ2 2024: $57MQ3 2024: $53MQ4 2024: $116MQ1 2025: $145MQ2 2025: $187MQ3 2025: $240MQ4 2025: $185MQ1 2026: $145MQ2 2026: $137MQ3 2026: $228M
Q4 2023: $42MQ1 2024: $54MQ2 2024: $57MQ3 2024: $53MQ4 2024: $116MQ1 2025: $145MQ2 2025: $187MQ3 2025: $240MQ4 2025: $185MQ1 2026: $145MQ2 2026: $137MQ3 2026: $228M
QuarterRevenueYoY
Q3 2026$228M-5.1%
Q2 2026$137.2M-27%
Q1 2026$144.8M0%
Q4 2025$184.7M+59%
Q3 2025$240.3M+355%
Q2 2025$187.3M+230%
Q1 2025$144.8M+168%
Q4 2024$116.1M+176%

IREN has the edge over FACT on sales, with more consistent year-over-year improvement.

FACT Free Cash Flow

Q4 2023: $147MQ1 2024: −$5MQ2 2024: $0Q3 2024: −$50,996Q4 2024: −$254,107Q1 2025: −$225,895Q2 2025: −$133,561Q3 2025: −$80,839Q4 2025: −$462,835Q1 2026: −$131,882Q2 2026: −$242,432Q3 2026: −$97,585
Q4 2023: $147MQ1 2024: −$5MQ2 2024: $0Q3 2024: −$50,996Q4 2024: −$254,107Q1 2025: −$225,895Q2 2025: −$133,561Q3 2025: −$80,839Q4 2025: −$462,835Q1 2026: −$131,882Q2 2026: −$242,432Q3 2026: −$97,585
QuarterFree cash flowYoY
Q3 2026-$97.6K-$16.7K
Q2 2026-$242.4K-$108.9K
Q1 2026-$131.9K+$94K
Q4 2025-$462.8K-$208.7K
Q3 2025-$80.8K-$29.8K
Q2 2025-$133.6K-$133.6K
Q1 2025-$225.9K+$4.7M
Q4 2024-$254.1K-100%

FACT's free cash flow was −$934,734 over the past year, against −$694,402 the year before. Free cash flow isn't a meaningful measure for financial services companies like FACT.

IREN Free Cash Flow

Q4 2023: −$29MQ1 2024: −$222MQ2 2024: −$163MQ3 2024: −$387MQ4 2024: −$134MQ1 2025: −$351MQ2 2025: $16MQ3 2025: −$38MQ4 2025: −$468MQ1 2026: −$874MQ2 2026: $482MQ3 2026: −$1.6B
Q4 2023: −$29MQ1 2024: −$222MQ2 2024: −$163MQ3 2024: −$387MQ4 2024: −$134MQ1 2025: −$351MQ2 2025: $16MQ3 2025: −$38MQ4 2025: −$468MQ1 2026: −$874MQ2 2026: $482MQ3 2026: −$1.6B
QuarterFree cash flowYoY
Q3 2026-$1.6B-$1.6B
Q2 2026$482.2M+2895%
Q1 2026-$873.8M-$523.1M
Q4 2025-$468M-$334M
Q3 2025-$38M+$349.4M
Q2 2025$16.1M+$179M
Q1 2025-$350.7M-$128.7M
Q4 2024-$134M-$105.2M

IREN has the edge over FACT on cash flow, with more consistent year-over-year improvement.

FACT Total Shares

Q4 2023: 25MQ1 2024: 25MQ2 2024: 25MQ3 2024: 5MQ4 2024: 25MQ1 2025: 24MQ2 2025: 24MQ3 2025: 18MQ4 2025: 24MQ1 2026: 18MQ2 2026: 18MQ3 2026: 24M
Q4 2023: 25MQ1 2024: 25MQ2 2024: 25MQ3 2024: 5MQ4 2024: 25MQ1 2025: 24MQ2 2025: 24MQ3 2025: 18MQ4 2025: 24MQ1 2026: 18MQ2 2026: 18MQ3 2026: 24M
PeriodChange %Net change
Quarterly+32%+5.8M shares
1 year+32%+5.8M shares
3 years-39%-15.5M shares
5 years-42%-17.7M shares

FACT has 24M diluted shares, up 32% from a year ago.

IREN Total Shares

Q4 2023: 73MQ1 2024: 112MQ2 2024: 186MQ3 2024: 189MQ4 2024: 210MQ1 2025: 219MQ2 2025: 257MQ3 2025: 362MQ4 2025: 298MQ1 2026: 334MQ2 2026: 316MQ3 2026: 399M
Q4 2023: 73MQ1 2024: 112MQ2 2024: 186MQ3 2024: 189MQ4 2024: 210MQ1 2025: 219MQ2 2025: 257MQ3 2025: 362MQ4 2025: 298MQ1 2026: 334MQ2 2026: 316MQ3 2026: 399M
PeriodChange %Net change
Quarterly+26%+82.4M shares
1 year+10%+36.9M shares
3 years+511%+333M shares
5 years+624%+344M shares
Available history+2346%+382M shares

IREN has the edge over FACT on shareholder dilution, with a more favorable share count trend.

FACT Net Leverage

Q3 2025: -1.2x
Q3 2025: -1.2x
QuarterNet LeverageStatus
Q3 2025-1.2xNet Cash
Q1 20230.6xVery low
Q4 20220.2xVery low
Q3 20220.1xVery low

FACT has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like FACT.

IREN Net Leverage

Q4 2023: -11.0xQ1 2024: -10.6xQ2 2024: -15.9xQ3 2024: -16.7xQ4 2024: -4.6xQ1 2025: 3.3xQ2 2025: 2.0xQ3 2025: 4.1xQ4 2025: 22.2xQ1 2026: 157.6x
Q4 2023: -11.0xQ1 2024: -10.6xQ2 2024: -15.9xQ3 2024: -16.7xQ4 2024: -4.6xQ1 2025: 3.3xQ2 2025: 2.0xQ3 2025: 4.1xQ4 2025: 22.2xQ1 2026: 157.6x
QuarterNet LeverageStatus
Q1 2026157.6xHigh
Q4 202522.2xHigh
Q3 20254.1xHigh
Q2 20252.0xModerate
Q1 20253.3xElevated
Q4 2024-4.6xNet Cash
Q3 2024-16.7xNet Cash
Q2 2024-15.9xNet Cash

IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.

FACT Weekly Momentum

MetricValueStatus
RSI76.0Overbought
Stochastic94.2Overbought

FACT's weekly RSI is 76 (overbought) and its Stochastic is 94 (overbought).

IREN Weekly Momentum

MetricValueStatus
RSI33.3Neutral
Stochastic8.2Oversold

IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).

FACT PE vs Financial Services Sector

MetricFACTSector medianRelative
PE60x13x360% above
PE %802258 pts above

FACT is trading at 60x earnings, a 360% premium to the Financial Services sector's median of 13x, though its earnings don't support one.

IREN PE vs Financial Services Sector

MetricIRENSector medianRelative
PEN/A13x—

IREN has no meaningful PE right now: it lost money over the past year.

FACT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$10.80.3% above
20 week MA$10.70.7% above
50 week MA$10.61.8% above
100 week MA$10.43.9% above

FACT has stronger trend alignment. FACT is above 4 of 4 weekly averages versus IREN above 1 of 5.

IREN Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$29.835% below
20 week MA$36.246% below
50 week MA$42.854% below
100 week MA$32.039% below
200 week MA$19.12.1% above

IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.

FACT Yearly ROI

YearStart priceEnd priceROI
2024$9.88$9.880%
2025$9.88$10.4+5.2%
2026 YTD$10.4$10.8+3.8%

FACT has the edge over IREN on returns for 2026, with the stronger performance.

IREN Yearly ROI

YearStart priceEnd priceROI
2021$24.8$17.2-31%
2022$17.2$1.19-93%
2023$1.19$7.15+501%
2024$7.15$10.7+50%
2025$10.7$40.3+276%
2026 YTD$40.3$19.5-52%

IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.

Give your agent the market.

Get API key